Fakultäten » Medizinische Fakultät » Biomedizinische Ethik und Medizingeschichte, Institut für » Prof. Dr. Nikola Biller-Andorno » Roduit

Completed research project

Title / Titel Enhancing short children? An ethical investigation of treating ‘short but healthy’ children with growth hormones
PDF Abstract (PDF, 14 KB)
Summary / Zusammenfassung According to current regulations in Switzerland treatment of short children with growth hormone is covered by health insurance only if a growth hormone deficiency has been diagnosed. Short children of short parents or idiopathic short stature (ISS) children, on the other hand, should theoretically be denied this treatment – even if their suffering from societal stigmatization and socioeconomic or sportive disadvantages might be equally severe. Is a substantially unequal treatment based on diagnosis justified or should Swiss pediatric endocrinologists give human Growth Hormone also to idiopathic short stature (ISS) children in Switzerland and what ethical considerations are included in a sound clinical evaluation and decision-making? In short: “Should Swiss pediatric endocrinologists give human Growth Hormone to ISS children in Switzerland?”. This question will be addressed around two project goals:

a)A descriptive account of the current practice in Switzerland of giving GH to children who are not hormone deficient or suffering from diseases.

b)An ethical analysis of the empirical data against the background of the larger debate on human enhancement, including possible policy implications.
Publications / Publikationen Roduit, Johann A R; Vincent, Menuz; Baumann, Holger (2014). Human Enhancement: Living Up to the Ideal Human [Chapter 4]. In: Thompson, Steven John. Global Issues and Ethical Considerations in Human Enhancement Technologies. Hershey PA : Idea Group: IGI Global, 54-66.
Keywords / Suchbegriffe human enhancement, growth hormones, endocrinologist, idiopathic short stature,
Project leadership and contacts /
Projektleitung und Kontakte
Dr Johann Roduit, A R (Project Leader)
Funding source(s) /
Unterstützt durch
The Swiss Academy of Medical Sciences (SAMS)
Duration of Project / Projektdauer Aug 2012 to Dec 2015